Qingdao Haier Biomedical Co Ltd (688139.SS) stock: key figures, P/E, revenue and dividend
Health Care · Health Care Equipment · China · ISIN CNE100003P25
Qingdao Haier Biomedical Co Ltd financials
| Fiscal year | 2024 | 2025 |
|---|---|---|
| Revenue | 2.28 bn CNY | 2.33 bn CNY |
| Gross profit | 1.10 bn CNY | 1.09 bn CNY |
| Operating income | 343.37 m CNY | 234.32 m CNY |
| EBIT | 405.37 m CNY | 268.67 m CNY |
| Net income | 366.63 m CNY | 250.73 m CNY |
| Diluted EPS – continuing operations | 1.15 CNY | 0.79 CNY |
Full history since 2016, charts and your own formulas
This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.
About Qingdao Haier Biomedical Co Ltd
Qingdao Haier Biomedical Co.,Ltd engages in the research and development, manufacture, marketing, and sale of low temperature storage equipment for biomedical samples in China and internationally. The company offers ULT freezers, pharmacy refrigerators, freezers, automatic storage solutions, cryogenics, active temperature controlled RKN containers, and RTMD products; and CO2 incubation, standard incubators, biological safety cabinets, clean benches and laminar, and sterilization products. It also provides floor standing, benchtop refrigerated, and benchtop centrifuges; intelligent pharmacy automation and RFID pharmacy products; blood bank refrigerators, blood component management products, blood plasma freezers, and transport coolers; and vaccine storage, cold/freezer room, medical waste disposal equipment, and other products. In addition, the company offers freezer and controlled rate freezers; microwave digestion system; UV visible spectrophotometer and total organic carbon analyzer products; and consumables. Further, it provides after-sales services; and U-biobank, U-vaccine, U-reagent, U-blood, and U-laboratory network solutions. The company serves hospitals, bio and pharmaceutical enterprises, universities and colleges, scientific research institutions, centers for disease control, primary public health institutions and blood stations. Qingdao Haier Biomedical Co.,Ltd was founded in 2005 and is based in Qingdao, China.
More stocks
- Charter Hall Retail REIT (CQR.AX)
- LegoChem Biosciences Inc (141080.KQ)
- Molten Ventures PLC (GROW.L)
- Etablissements Maurel et Prom SA (MAU.PA)
- Altus Group Ltd (AIF.TO)
- Tokuyama Corp (4043.T)
- Generate Biomedicines, Inc. Common Stock (GENB)
- Trustpilot Group PLC (TRST.L)
- Pets at Home Group PLC (PETS.L)
- C3.ai, Inc. (AI)
- Yusys Technologies Co Ltd Class A (300674.SZ)
- Essence Fastening Systems (Shanghai) Co. Ltd. (301005.SZ)
Not investment advice. All data without warranty, price as of 02.11.2026. Details in the risk notice.